Committee reports
17-18 December 2008 meeting
Safety of rotavirus vaccines; Safety of human papillomavirus vaccines; Vaccine safety alerts; GACVS subgroups.
Full report in WER (pdf 171kb)
html version
18-19 June 2008 meeting
Safety of yellow fever vaccine; Diphtheria-tetanus-pertussis vaccine and asthma; Non-specific effects of DTP vaccine on child mortality; Pregnancy outcomes after inadvertent immunization with rubella vaccine; Mitochondrial diseases and vaccination;Thiomersal; Report from subgroups.
Full report in WER (pdf 194kb)
html version
12-13 December 2007 meeting
Guillain-Barré syndrome and vaccination; Safety of immunization in immunocompromised individuals; Safety of yellow fever vaccines; Hepatitis B vaccination and rheumatoid arthritis; Safety of live 14-14-2 Japanese encephalitis vaccine; Safety of meningococcal B vaccines; Rotavirus vaccines and Kawasaki disease; Modus operandi of the committee and additional information.
Full report in WER (pdf 245kb)
html version
12-13 June 2007 meeting
Monitoring vaccine safety; Safety of vaccine formulations; Mumps vaccine virus strain repository; Safety of BCG vaccines; Safety of human papillomavirus vaccine; Update on Menactra® and Guillain-Barré syndrome; Safety of rotavirus vaccines; Influenza vaccines: update; Modus operandi of the Committee and additional information.
Full report in WER (pdf 7.40Mb)
html version
29-30 November 2006 meeting
Monitoring vaccine safety; Report of the WHO Expert Committee on Biological Standardization; Safety of vaccine formulations; Vaccinating adolescents and young adults: problems with coincidental pathologies and safety assessments; Safety of mumps vaccine strains; Safety of BCG vaccine in HIV-infected children; Update on Menactra® and Guillain-Barré syndrome; Pandemic influenza vaccines; Safety of Japanese encephalitis vaccination in India; Safety of pneumococcal conjugate vaccine.
Full report in WER (pdf 284kb)
html version
6-7 June 2006 meeting
Vaccine safety monitoring and the WHO Programme for International Drug Monitoring; Post-marketing surveillance of rotavirus vaccines; Safety of squalene; Immunogenic overload; Safety of pandemic influenza vaccines; Safety issues of varicella vaccines; Modus operandi of the Committee and additional information
Full report in WER (pdf 241kb)
html version
1-2 December 2005 meeting
Vaccine Safety Net; Safety issues associated with pandemic influenza vaccines; Safety of adjuvants; Rotavirus vaccine safety; Subacute sclerosing panencephalitis and measles vaccination; Chronic fatigue syndrome and hepatitis B vaccination; Conjugate meningococcal vaccine and Guillain-Barré Syndrome; Modus operandi of the Committee.
Full report in WER (pdf 154kb)
html version
9-10 June 2005 meeting
Mouse brain-derived Japanese encephalitis vaccine; Safety of SA 14-14-2 Japanese encephalitis vaccine; Isoniazid resistance of bacille Calmette-Guérin strains; International drug monitoring; Thiomersal; Safety of hexavalent vaccines; Subacute sclerosing panencephalitis and measles vaccination; National regulatory authorities planning workshops.
Full report in WER (pdf 155kb)
html version
2-3 December 2004 meeting
Safety of adjuvants; Thiomersal: neurobehavioural studies on animal models; Safety of residual cellular DNA in vaccines; Transmissible spongiform encephalopathy; Potential risk of vaccines produced on yeast; Safety of hexavalent vaccines; Yellow fever; Vaccine Safety Net.
Full report in WER (pdf 233kb)
html version
10-11 June 2004 meeting
Safety of adjuvants; Dengue vaccine safety; Effect of diphtheria-tetanus-pertussis (DTP) vaccination on child survival
Full report in WER (pdf 244kb)
html version
3–4 December 2003 meeting
Intranasal influenza virus vaccine; Influenzae vaccines and neurological complications; Influenza vaccination of women during pregnancy; Nonspecific effects of childhood immunization; Safety issues in the poliomyelitis eradication campaign; International reference laboratory for mumps virus isolates; Yellow fever vaccine safety; BCG immunization in HIV-positive subjects; Safety of smallpox vaccination; Switch from rubella vaccine to mumps, measles and rubella vaccine; Aluminium-containing vaccines and macrophagic myofasciitis.
Full report in WER (pdf 561kb)
html version
11-12 June 2003 meeting
Adverse events following mumps vaccination; Safety of smallpox vaccines; Safety of BCG vaccination in immunocompromised individuals; Thiomersal
Full report in WER (pdf 458kb)
16-17 December 2002 meeting
MMR and autism; Oculorespiratory syndrome; Hepatitis B vaccination and leukaemia
Full report in WER (pdf 228kb)
20-21 June 2002 meeting
Safety of thiomersal-containing vaccines; Hepatitis B vaccine and leukaemia; Hepatitis B vaccine and multiple sclerosis; Aluminium-containing vaccines and macrophagic myofasciitis; Bell palsy following intranasal vaccination; Potential adverse impact of routine vaccination on child survival
Full report in WER (pdf)
html version
23 March 2001
Causality assessment of adverse events following immunization
Full report in WER (pdf)
15 October 1999
About GAVCS; Macrophagic myofasciitis and aluminium-containing vaccines
Full report in WER (pdf)
Corrigendum (pdf)
|
